Physician profile
Robert D Hoff
NPI 1659388908
$8,071.91
in general payments reported to CMS, 2019-2025
25 companies · $402 in 2025
The $402 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $1,748 · 2021: $1,627 · 2022: $1,409 · 2023: $737 · 2024: $458 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,385.20 | 2019-2024 | Jardiance |
| Amgen INC. | $1,353.45 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,235.48 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $579.43 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $541.54 | 2019-2024 | Xarelto |
| Pfizer INC. | $488.44 | 2019-2025 | |
| Amarin Pharma, INC. | $448.10 | 2019-2022 | |
| Esperion Therapeutics, INC. | $399.01 | 2020-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $302.75 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $242.76 | 2020-2024 | Wainua |
| Sanofi-Aventis U.S. LLC | $179.16 | 2019-2022 | |
| Medtronic Vascular, INC. | $162.70 | 2019 | |
| Boston Scientific Corporation | $140.79 | 2020-2023 | Watchman Access System, Watchman Flx |
| Edwards Lifesciences Corporation | $119.69 | 2019-2024 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $105.73 | 2019-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $88.09 | 2019-2022 | |
| Inspire Medical Systems, INC. | $81.02 | 2024-2025 | Inspire |
| Arbor Pharmaceuticals, INC. | $76.12 | 2019-2020 | |
| Bracco Diagnostics INC. | $37.65 | 2022 | |
| Lundbeck LLC | $22.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.68 | 2021 | |
| Heartflow, INC. | $18.60 | 2022 | |
| Cardiva Medical, INC. | $17.40 | 2022 | |
| Medtronic, INC. | $14.00 | 2024 | Venaseal |
| Allergan, INC. | $13.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.